Swiss - Delayed Quote CHF
Cosmo Pharmaceuticals N.V. (COPN.SW)
47.65
+0.35
+(0.74%)
At close: 5:31:45 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
162,411
162,411
22,708
33,226
12,611
Investing Cash Flow
-128,881
-128,881
53,218
1,689
24,857
Financing Cash Flow
-40,224
-40,224
-211,266
-46,133
-27,247
End Cash Position
44,296
44,296
50,275
185,825
198,560
Capital Expenditure
-5,653
-5,653
-4,396
-7,310
-8,504
Issuance of Capital Stock
3,377
3,377
687
270
761
Repayment of Debt
-1,076
-1,076
-176,028
-916
-2,624
Repurchase of Capital Stock
-5,931
-5,931
-12,475
-24,747
-20,506
Free Cash Flow
156,758
156,758
18,312
25,916
4,107
12/31/2021 - 3/12/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NVSEF Novartis AG
111.41
0.00%
NOV.DE Novo Nordisk A/S
54.20
-1.38%
AMRN Amarin Corporation plc
10.68
-4.47%
ROG.SW Roche Holding AG
261.90
-0.15%
AMGN Amgen Inc.
279.32
-0.19%
BMY Bristol-Myers Squibb Company
47.38
-2.69%
JNJ Johnson & Johnson
153.57
-0.88%
MRK Merck & Co., Inc.
80.81
+1.21%
ABBV AbbVie Inc.
184.70
+2.40%
LLY Eli Lilly and Company
869.00
+1.08%